This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (5)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

RICHARD E. SAMPLINER, MD

Arch Intern Med. 1990;150(5):945-946.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The medical literature is replete with studies of fecal occult blood tests, as documented in the references of the articles by Stelling et al¹ and See also pp 1001 and 1041. Ahlquist et al² in this issue of the ARCHIVES. Much of the assessment of fecal occult blood testing has been in the area of screening for colorectal carcinoma, a subject recently well reviewed.^3,4 Ahlquist et al² emphasize that even with the use of HemoQuant, a sensitive measure of gastrointestinal (GI) tract bleeding, 41% of patients with symptomatic colorectal cancers had a negative result of a fecal occult blood test. In relation to other tests, HemoQuant requires greater stool sampling. This study is limited by its retrospective nature and failure to define why 40 patients did not qualify. An interesting finding was significantly higher positivity when testing was performed before bowel preparation for diagnostic studies. The . . . [Full Text PDF of this Article]

Author Affiliations
Section of Gastroenterology University of Arizona and Tucson Veterans Affairs Medical Center

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?